Pfizer's $3.5 Billion Cost-Cutting Program Amid Lagging COVID Injection Sales - PJ Media

Retrieved on: 2023-10-21 18:18:35

Tags for this article:

COVID-19 pandemic by country

COVID-19 vaccination in the United States

RNA vaccines

Pfizer

Research and development in the United States

COVID-19 vaccine

Vaccine

Nirmatrelvir/ritonavir

COVID-19 vaccination in South Africa

COVID-19 vaccination in Thailand

Click the tags to see associated articles and topics

Pfizer's $3.5 Billion Cost-Cutting Program Amid Lagging COVID Injection Sales - PJ Media. View article details on HISWAI: https://pjmedia.com/news-and-politics/benbartee/2023/10/21/auto-draft-11-n1736986

Excerpt

Pfizer's latest COVID booster isn't going super well. Only about 2% of the entire American population has been successfully injected, ...

Article found on: pjmedia.com

View Original Article